VEGFA and neoplasm: Once induced, MDSCs promote an immune-suppressive TME by inhibiting anti-tumorigenic T cells and promoting tumor vascularization via vascular endothelial growth factor (VEGF), extracellular matrix modification through matrix metalloproteinases (MMPs), and ultimately tumor progression.